Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Return on Invested Capital (2023 - 2025)

Eton Pharmaceuticals' Return on Invested Capital history spans 3 years, with the latest figure at 0.03% for Q3 2025.

  • For Q3 2025, Return on Invested Capital rose 19.0% year-over-year to 0.03%; the TTM value through Sep 2025 reached 0.03%, up 19.0%, while the annual FY2024 figure was 0.02%, 1.0% down from the prior year.
  • Return on Invested Capital for Q3 2025 was 0.03% at Eton Pharmaceuticals, down from 0.03% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.07% in Q1 2024 and bottomed at 0.28% in Q2 2024.
  • The 3-year median for Return on Invested Capital is 0.02% (2024), against an average of 0.06%.
  • The largest YoY upside for Return on Invested Capital was 31bps in 2025 against a maximum downside of -8bps in 2025.
  • A 3-year view of Return on Invested Capital shows it stood at 0.01% in 2023, then tumbled by -101bps to 0.02% in 2024, then plummeted by -60bps to 0.03% in 2025.
  • Per Business Quant, the three most recent readings for ETON's Return on Invested Capital are 0.03% (Q3 2025), 0.03% (Q2 2025), and 0.01% (Q1 2025).